市场调查报告书
商品编码
1616692
復健机器人市场机会、成长动力、产业趋势分析及2024年至2032年预测Rehabilitation Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
2023年全球康復机器人市场价值为2.464亿美元,预计2024-2032年复合年增长率为22.2%。大脑相关疾病盛行率的上升极大地推动了康復机器人市场的全球成长。中风、阿兹海默症、帕金森氏症和癫痫等疾病通常会导致长期残疾,需要广泛的復健治疗。例如,世界卫生组织 (WHO) 报告称,全球约有 5,000 万人患有癫痫症,其中近 80% 居住在低收入和中等收入国家。此外,每年估计有 500 万个新诊断病例。
随着这些疾病变得越来越普遍,对有效復健策略的需求不断增加。 2023 年,治疗机器人领域引领市场,产生约 1.66 亿美元的收入。
治疗机器人提供一致、高品质的復健课程,通常减少对人类治疗师的依赖。这不仅降低了整体復健成本,还允许更频繁和延长疗程,这对于有效康復至关重要,使其越来越受到患者的青睐。此外,治疗机器人具有多功能性,可以解决中风以外的疾病,例如脊髓损伤、创伤性脑损伤、多发性硬化症和骨科问题。它们广泛的适用性增强了它们在不同医疗保健环境中的价值。
市场范围 | |
---|---|
开始年份 | 2023年 |
预测年份 | 2024-2032 |
起始值 | 2.464 亿美元 |
预测值 | 14亿美元 |
复合年增长率 | 22.2% |
市场也依机器人结构分为末端执行器机器人和外骨骼机器人。预计到 2032 年,末端执行器机器人领域将引领市场,预计收入约为 8.989 亿美元。这种适应性允许进行多样化的復健锻炼,适合各种关节和肌肉群,从而满足广大患者的需求。此外,其用户友好的设计意味着它们可以快速设置,并针对不同患者进行调整,并且不需要大量校准。
这种便利性对治疗师和患者都有好处,确保临床整合更加顺利。中风、脊髓损伤、多发性硬化症和帕金森氏症等疾病在北美很普遍。随着这些情况继续恶化,预计将推动市场成长。
此外,北美医疗保健提供者越来越多地采用循证实践,将机器人技术整合到復健计画中,以改善患者的治疗效果,进一步推动市场扩张。
The Global Rehabilitation Robots Market was valued at USD 246.4 million in 2023 and is projected to expand at a CAGR of 22.2% from 2024-2032. The worldwide growth of the rehabilitation robot market is being significantly propelled by the rising prevalence of brain-related disorders. Conditions like stroke, Alzheimer's, Parkinson's, and epilepsy often lead to long-term disabilities, necessitating extensive rehabilitation. For example, the World Health Organization (WHO) reports that around 50 million people worldwide suffer from epilepsy, with nearly 80% residing in low- and middle-income nations. Furthermore, each year sees an estimated 5 million new diagnoses.
As these disorders become more prevalent, the demand for effective rehabilitation strategies intensifies.The overall rehabilitation robots industry is classified based on type, application, end-use, and region.The rehabilitation robots market is segmented by type into assistive robots and therapy robots. In 2023, the therapy robot segment led the market, generating approximately USD 166 million in revenue.
Therapy robots offer consistent, high-quality rehabilitation sessions, often diminishing the reliance on human therapists. This not only reduces overall rehabilitation costs but also permits more frequent and extended sessions, crucial for effective recovery, making them increasingly preferred by patients. Additionally, therapy robots boast versatility, addressing conditions beyond stroke, such as spinal cord injuries, traumatic brain injuries, multiple sclerosis, and orthopedic issues. Their broad applicability enhances their value across varied healthcare environments.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $246.4 Million |
Forecast Value | $1.4 Billion |
CAGR | 22.2% |
The market is also segmented by robotic structure into end-effector robots and exoskeleton robots. The end-effector robots segment is projected to lead the market with an anticipated revenue of around USD 898.9 million by 2032. End-effector robots enable a broad range of motion at their interaction point with patients, typically the hand or foot. This adaptability allows for diverse rehabilitation exercises, catering to various joints and muscle groups, thus meeting the needs of a wide patient demographic. Moreover, their user-friendly design means they can be swiftly set up, adjusted for different patients, and don't demand extensive calibration.
This accessibility benefits both therapists and patients, ensuring smoother clinical integration.In 2023, North America accounted for USD 106.9 million in revenue from the rehabilitation robots market and is poised for significant growth in the coming years. Conditions like stroke, spinal cord injuries, multiple sclerosis, and Parkinson's disease are prevalent in North America. As these conditions continue to rise, they are expected to fuel market growth.
Moreover, North American healthcare providers are increasingly adopting evidence-based practices, integrating robotics into rehabilitation programs to enhance patient outcomes, further propelling market expansion.